missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ HVEM/TNFRSF14 Human ELISA Kit
Sandwich ELISA Kit
Brand: Invitrogen™ EHTNFRSF14X5
This item is not returnable.
View return policy
Description
The Human Herpes Virus Entry Mediator (HVEM/TNFSF14) ELISA quantitates Hu HVEM in human serum, plasma, or cell culture medium. The assay will exclusively recognize both natural and recombinant Hu HVEM. Principle of the method The Human HVEM solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
TNFRSF14 is a member of the TNF-receptor superfamily. TNFRSF14 was identified as a cellular mediator of herpes simplex virus (HSV) entry. Binding of HSV viral envelope glycoprotein D (gD) to TNFRSF14 has been shown to be part of the viral entry mechanism. The cytoplasmic region of TNFRSF14 was found to bind to several TRAF family members, which may mediate the signal transduction pathways that activate the immune response. Activation of the signal transduction pathway involving TNFRSF14 in T cells stimulates T cell proliferation and cytokine production, leading to inflammation and enhanced CTL-mediated tumor immunity, suggesting that these proteins may be useful as potential targets for controlling cellular immune responses. Multiple alternatively spliced transcript variants have been described, but the full-length nature of some of these TNFRSF14 variants have not been determined.
Specifications
| Q92956 | |
| 30 pg/mL | |
| Solid-phase sandwich ELISA | |
| ELISA Kit | |
| Plasma, Serum, Supernatant | |
| 5 x 96 assays | |
| ELISA, Protein Assays, Protein Biology, Cancer Biology, Immunology, Neuroscience, Neurobiology, Protein Detection, Protein Analysis | |
| 8764 | |
| <12% | |
| SAV-HRP, Wash Buffer, Adhesive Plate Covers, Pre-coated 96 well plates, Chromogen, Assay Diluent Concentrate, Stop Solution, Biotinylated Detection Antibody, Standard | |
| 5 x 96 Tests | |
| Biomarker-Related Pathways | |
| 2°C to 8°C | |
| Human | |
| 4 hr. 45 min. |
| 32.77 pg/mL to 8000 pg/mL | |
| 30 pg/mL to 8000 pg/mL | |
| Biotin | |
| Cytokines & Receptors | |
| This ELISA kit shows no cross-reactivity with the following cytokines tested: human Angiogenin, BDNF, BLC, CNTF, ENA- 78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL- 11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, FGF-4, FGF-6, FGF- 7, G-CSF, GDNF, GM-CSF, IFN-gamma, IGFBP-2, IGFBP-3, IGFBP-4, Leptin (OB), MCP-1, MCP-2, MDC, MIF, MIG, MIP-1 alpha, MIP-1 beta, MIP-1 delta, PARC, PDGF, RANTES, SCF, SDF-1 alpha, TARC, TGF-beta, TIMP-1, TIMP- 2, TNF-alpha, TNF-beta, TPO, VEGF. | |
| Human | |
| Colorimetric Microplate Reader | |
| CD258,HVEML,LIGHT,LTg | |
| <10% | |
| HRP | |
| RUO | |
| Plasma, 50 μ;L; Serum, 50 μ;L; Supernatant, 100 μ;L | |
| RP3-395M20.6, ATAR, CD270, HVEA, HVEM, LIGHTR, TR2 | |
| 1 hr. 20 min. |